Bulletin
Investor Alert

CymaBay Therapeutics Inc.

NAS: CBAY

GO
/marketstate/country/us

After Hours

/zigman2/quotes/201917619/composite

$

5.42

Change

0.00 0.00%

Volume

Volume 1,458

Nov 15, 2019, 5:09 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/201917619/composite

Today's close

$ 5.38

$ 5.42

Change

+0.04 +0.74%

Day low

Day high

$5.18

$5.49

Open
Open: 5.42

52 week low

52 week high

$4.23

$14.00

Open

Market cap

$370.99M

Average volume

671,183

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-1.43

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/cbay

MarketWatch News on CBAY

  1. CymaBay Therapeutics started at buy with $14 stock price target at Stifel Nicolaus

    6:45 a.m. June 25, 2019

    - Tomi Kilgore

  2. CymaBay Therapeutics stock price target cut to $7 from $11 at B. Riley FBR

    11:15 a.m. June 17, 2019

    - Tomi Kilgore

  3. CymaBay Therapeutics upgraded to strong buy from market outperform at Raymond James

    6:27 a.m. June 12, 2019

    - Tomi Kilgore

  4. CymaBay Therapeutics started at neutral with $9 stock price target at B. Riley FBR

    9:08 a.m. Feb. 6, 2019

    - Tomi Kilgore

  5. CymaBay Therapeutics reiterated as buy at SunTrust Robinson Humphrey

    7:46 a.m. Dec. 31, 2018

    - Ciara Linnane

  6. 4 charts to watch as tech stocks rebound

    11:18 a.m. Feb. 14, 2018

    - Harry Boxer

  7. CymaBay Therapeutics started at outperform with $35 stock price target at Evercore ISI

    7:40 a.m. Feb. 13, 2018

    - Tomi Kilgore

  8. Harry Boxer’s momentum stocks to watch this week

    10:12 a.m. Oct. 25, 2017

    - Harry Boxer

  9. CymaBay Therapeutics started at buy with $15 stock price target at SunTrust RH

    6:35 a.m. Aug. 18, 2017

    - Tomi Kilgore

Analyst Ratings

/news/nonmarketwatch/company/us/cbay

Other News on CBAY

  1. CymaBay Therapeutics (CBAY) Investor Presentation - Slideshow

    2:55 p.m. Nov. 8, 2019

    - Seeking Alpha

  2. CymaBay presenting two abstracts at Liver Meeting

    3:52 p.m. Oct. 1, 2019

    - Seeking Alpha

  3. 7 Stocks the Insiders Are Buying on Sale

    1:13 p.m. Oct. 1, 2019

    - InvestorPlace.com

  4. Genfit And GenKyoTex In PBC: What To Expect In Phase 3

    4:18 p.m. Aug. 20, 2019

    - Seeking Alpha

  5. CymaBay And Seladelpar In PSC: The Imminent Phase 2 Study

    5:16 p.m. Aug. 16, 2019

    - Seeking Alpha

  6. 10-Q: CYMABAY THERAPEUTICS, INC.

    3:06 p.m. Aug. 7, 2019

    - Edgar Online - (EDG = 10Q, 10K)

  7. Eli Lilly And Baricitinib In PBC: What's The Story?

    2:47 p.m. July 10, 2019

    - Seeking Alpha

  8. Stifel likes Viking Therapeutics in premarket analyst action

    7:25 a.m. June 25, 2019

    - Seeking Alpha

  9. CymaBay +2.8% on new Buy rating at Stifel

    4:20 p.m. June 24, 2019

    - Seeking Alpha

  10. Loading more headlines...

Earnings Announcement

/news/pressrelease/company/us/cbay

Press Releases on CBAY

  1. Tuesday 10/15 Insider Buying Report: CBAY

    10:37 a.m. Oct. 15, 2019

    - MarketNewsVideo.com

  2. Loading more headlines...

Rates »

Link to MarketWatch's Slice.